| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 10/31/2006 | US7128932 Formulations useful in the treatment of male and female impotence |
| 10/31/2006 | CA2154955C Two component dentifrice for the treatment of dentinal hypersensitivity |
| 10/31/2006 | CA2142811C Novel glucan preparation |
| 10/26/2006 | WO2005051294A3 Recovery of phytonutrients from oils |
| 10/26/2006 | WO2005041891A3 Neutrophil activation by immune response modifier compounds |
| 10/26/2006 | WO2005020888A3 Compositions and methods of treating and diagnosing hepatoma |
| 10/26/2006 | WO2005011599A3 Antibodies specific for toxic amyloid beta protein oligomers |
| 10/26/2006 | WO2004078147A3 Oxytocin controlled release formulations and methods of using same |
| 10/26/2006 | US20060241166 Sapphyrins and uses thereof |
| 10/26/2006 | US20060241149 Chemical compounds |
| 10/26/2006 | US20060241133 Electrically variable pneumatic structural element |
| 10/26/2006 | US20060241130 Anti-inflammatory compositions and uses thereof |
| 10/26/2006 | US20060241122 Combination therapy for the treatment of neoplasms |
| 10/26/2006 | US20060241110 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 10/26/2006 | US20060241107 Androgen receptor modulators and methods of use thereof |
| 10/26/2006 | US20060241099 Use of 2-thia-dibenzo[e,h]azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 10/26/2006 | US20060241089 Dipyridamole, acetylsalicylic acid, and angiotensin II antagonist pharmaceutical compositions |
| 10/26/2006 | US20060241030 Irs modulators |
| 10/26/2006 | US20060241029 administering to an individual a therapeutically or prophylactically effective dosage regime of a hypocretin or an agonist thereof, and monitoring the condition of the individual responsive to the administering |
| 10/26/2006 | US20060241024 Intermediate for preparing glycopeptide derivatives |
| 10/26/2006 | US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity |
| 10/26/2006 | US20060240519 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 10/26/2006 | US20060240517 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060240441 Gene expression profiles and methods of use |
| 10/26/2006 | US20060240085 Treatment of dependence withdrawal |
| 10/26/2006 | US20060240080 Alginate sponge and preparation method thereof |
| 10/26/2006 | US20060239988 Neuronal regeneration and compound administration methods |
| 10/26/2006 | US20060239970 Herpesvirus amplicon particles |
| 10/26/2006 | US20060239933 Medical product |
| 10/25/2006 | EP1713456A1 Rectal composition |
| 10/25/2006 | EP1517909B1 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 10/25/2006 | EP1309308B1 Epilatory compositions |
| 10/25/2006 | EP1286672B1 S-methyl-dihydro-ziprasidone for the treatment of ocular disorders. |
| 10/25/2006 | EP0977599B1 Contrast agents comprising an azeotropic mixture of two gases for ultrasound investigations |
| 10/25/2006 | CN1852977A Expression of dominant negative transmembrane receptors in the milk of transgenic animals |
| 10/25/2006 | CN1852917A Synergisitic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 10/25/2006 | CN1852913A Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives |
| 10/25/2006 | CN1852748A Azepine derivatives as pharmaceutical agents |
| 10/25/2006 | CN1852728A Host defense factor X (HDFX) |
| 10/25/2006 | CN1852727A Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives |
| 10/25/2006 | CN1852722A Methods and pharmaceutical compositions for healing wounds |
| 10/25/2006 | CN1852711A Infection prophylaxis using immune response modifier compounds |
| 10/25/2006 | CN1852702A Sterile preparations of phospholipids and anti-inflammatory pharmaceuticals and methods for making and using same |
| 10/25/2006 | CN1852687A Method for the preparation of controlled release formulations |
| 10/25/2006 | CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones |
| 10/24/2006 | US7125985 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 10/24/2006 | US7125967 Water-soluble chitosan having low endotoxin concentration and methods for making and using the same |
| 10/24/2006 | US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 10/24/2006 | US7125879 Prevention reproduction of virus |
| 10/24/2006 | US7125870 such as N-hydroxy-2-{3-[4-(2-methyl-quinolin-4-ylmethoxy)-phenyl]-4,5-dihydro-isoxazol-5-yl}-acetamide; kits; for treatment of inflammation |
| 10/24/2006 | US7125854 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites |
| 10/24/2006 | US7125564 Glycyrrhizin complex |
| 10/24/2006 | CA2398963C New salt form and polymorphs |
| 10/24/2006 | CA2220682C Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions |
| 10/24/2006 | CA2168023C Vasoconstrictive substituted aryloxyalkyl diamines |
| 10/19/2006 | WO2005034860A3 Thiol reactive agents as a therapeutic modality |
| 10/19/2006 | WO2005023182A3 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 10/19/2006 | WO2004084810A3 Novel imidazoline receptor homologs |
| 10/19/2006 | US20060235477 Adaptive resynchronization therapy system |
| 10/19/2006 | US20060235220 Dipeptide nitriles |
| 10/19/2006 | US20060235079 Process for the preparation of gabapentin form-II |
| 10/19/2006 | US20060235069 Benzamide modulators of metabotropic glutamate receptors |
| 10/19/2006 | US20060235000 Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders |
| 10/19/2006 | US20060234991 Combinations for the treatment of immunoinflammatory disorders |
| 10/19/2006 | US20060234931 Treatment of diseases with kinase inhibitors |
| 10/19/2006 | US20060234235 Methods and compositions for the diagnosis of neuroendocrine lung cancer |
| 10/19/2006 | US20060233884 Sexual hygienic composition |
| 10/19/2006 | US20060233861 Modulation of atp production or content in the hypothalamus |
| 10/19/2006 | US20060233843 Treatment of psychosis with a muscarinic m1 receptor ectopic activator |
| 10/19/2006 | US20060233835 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 10/19/2006 | US20060233794 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 10/19/2006 | US20060233782 Polypeptide; a deletion mutant of chondroitinase ABC Type I truncated by a deletion; retains its proteoglycan degrading activity; neurological functional recovery after central nervous system injury or disease |
| 10/19/2006 | US20060230983 Treating the the aqueous extract containing a red colorant with a cation exchange resin to associate the colorant with the resin;and eluting the colorant from the resin with an eluting solution containing an alcohol and an acid to yield a red-colored eluate |
| 10/18/2006 | EP1711527A2 Hla-dr-specific antibodies, compositions and methods |
| 10/18/2006 | EP1395232B1 Cosmetic composition for nails, free of phthalates, camphor and aromatic solvent |
| 10/18/2006 | EP1283828B1 Novel polymorph v of torasemide |
| 10/18/2006 | CN1849337A Compositions and methods for treating cancer using IGSF9 and LIV-1 |
| 10/18/2006 | CN1849329A CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 10/18/2006 | CN1849313A 抗生素化合物 Antibiotic compounds |
| 10/18/2006 | CN1849131A Treating immunological disorders using agonists of interleukin-21 / interleukin-21 receptor |
| 10/18/2006 | CN1849112A Therapeutic liposomes |
| 10/18/2006 | CN1847253A Process for preparing amine platinum complexes |
| 10/18/2006 | CN1280286C Process for the industrial synthesis of thiophenecarboxylicacid, and application thereof |
| 10/17/2006 | US7122526 Topoisomerase I inhibitors; such as 2,3-methylenedioxy-6-hydroxymethyl-9-hydroxy-12-(beta-D-glucopyranosyl) -6,7,12,13-tetrahydroindolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione |
| 10/17/2006 | US7122525 Targeted therapeutics and uses thereof |
| 10/17/2006 | US7122361 Compositions employing a novel human kinase |
| 10/17/2006 | CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 10/17/2006 | CA2197207C Hiv protease inhibitor combination |
| 10/12/2006 | WO2005051320A3 Gcks as modifiers of branching morphogenesis and methods of use |
| 10/12/2006 | WO2005041885A3 Compositions and methods for treating, preventing, reversing and inhibiting pain |
| 10/12/2006 | WO2005027856A3 Inhibitors of anthrax lethal factor |
| 10/12/2006 | WO2004112703A3 Interleukin-21 analogs |
| 10/12/2006 | WO2004062621A3 Anti-inflammatory agents and methods of their use |
| 10/12/2006 | US20060229470 Calcium receptor-active molecules |
| 10/12/2006 | US20060229366 Method for preventing or treating respiratory infections in infants |
| 10/12/2006 | US20060229353 Substituted heterocycles |
| 10/12/2006 | US20060229340 Composition for improving cognition and memory |
| 10/12/2006 | US20060229321 Rosuvastatin in pre demented states |
| 10/12/2006 | US20060229303 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example |